Current methods for evaluating proptosis and other eye measurements require in-person hospital visits, which can be inconvenient for patients and limit access to timely assessments. There is a need for a reliable, at-home solution that enables real-time, precise measurements to reduce presurgery visits and facilitate postoperative evaluations remotely.
A healthcare technology company aiming to provide accessible ophthalmological diagnostics through innovative AI-driven solutions for remote patient monitoring and post-surgery evaluation.
The deployment of this AI-powered remote ophthalmological assessment platform is expected to significantly improve patient outcomes by enabling accurate, real-time measurements from home. It will reduce the dependency on in-person visits, leading to a more accessible healthcare experience, and increase the capacity of healthcare providers, thereby boosting revenue. Additionally, leveraging advanced AI and synthetic data generation will position the company as a leader in healthcare innovation, offering a scalable solution with competitive advantages.